# STIMUFEND

NDC: 65219-371
Generic name: pegflilgrastim-fpgk
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20221006

FDA application: BLA761173

## Active ingredients

- PEGFILGRASTIM: 6 mg/.6mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"65219-371"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=65219-371
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b44bcb82-7e60-4dab-a658-115bdf5c053c